September 2025
1. CAMPBELL A, Pruett TL
   Revisiting the Biological Rationale for Cytomegalovirus Immune Globulin (CMVIG) in the Modern Era of Solid Organ Transplantation: Current State and Future Direction.
   Transplant Proc. 2025 Sep 12:S0041-1345(25)00381.
   

   >> Share

   
   August 2025
2. TANRIVERDI ES, Yakupogullari Y, Bayindir Y, Akbulut S, et al
   Predictive Value of Pretransplant Cytomegalovirus-Specific Cellular Immunity for Posttransplant CMV Infection in Liver Transplant Recipients Under Antiviral Prophylaxis.
   Transplant Proc. 2025 Aug 12:S0041-1345(25)00351.
   

   >> Share

   
   June 2025
3. YILMAZ LZB, Memisoglu F, Hidayet E, Kuku I, et al
   Cytomegalovirus Infection Risk Factors in Allogeneic Hematopoietic Stem Cell Transplantation Can Defibrotide Be a Risk Factor?
   Transplant Proc. 2025 Jun 27:S0041-1345(25)00281.
   

   >> Share

   
   May 2025
4. PAULWITZ J, Vonbrunn L, Heller K, Dieterle A, et al
   Preemptive Conversion to mTOR Inhibition to Prevent Primary Cytomegalovirus Infection in Kidney Transplantation with High-Risk Serostatus.
   Transplant Proc. 2025 May 8:S0041-1345(25)00224.
   

   >> Share

   
   April 2025
5. YILMAZ B, Ersan S, Mingsar G, Tanrisev M, et al
   COVID-19 Infection May Lead to Increased CMV Infection in Renal Transplant Recipients.
   Transplant Proc. 2025 Apr 29:S0041-1345(25)00207.
   

   >> Share

   
   March 2025
6. PANDO-CACIANO A, Mamani-Cajachagua PE, Ingunza-Tapia AA, Sanchez-Garcia GJ, et al
   Saliva Samples as a Potential Tool for the Diagnosis and Monitoring of Cytomegalovirus Reactivation in Children Undergoing Transplantation.
   Transplant Proc. 2025 Mar 10:S0041-1345(25)00103.
   

   >> Share

   
   February 2025
7. ANJA K, Andro K, Luciana K, Marta K, et al
   Is Cytomegalovirus (CMV) Associated With Development of Posttransplant Psychosis? A Case Report and Review of the Literature.
   Transplant Proc. 2025 Feb 26:S0041-1345(25)00089.
   

   >> Share

   
   
8. PAWLOWSKA A, Kwella N, Zbrzezniak-Suszczewicz J, Knysak M, et al
   First Use of Maribavir in Poland to Treat Refractory CMV Disease in a Patient After Kidney Transplantation.
   Transplant Proc. 2025 Feb 24:S0041-1345(25)00083.
   

   >> Share

   
   January 2025
9. SEVERO A, Gonzalez Martin J, Mateo Gomez C, Arias Mahiques J, et al
   High-risk Cytomegalovirus in Heart Transplant: How Can We Improve?
   Transplant Proc. 2025 Jan 2:S0041-1345(24)00664.
   

   >> Share

   
   December 2024
10. LI D, Liu C, Kang Z, Zheng Y, et al
    Imbalances of Th1/Th2 and Tc1/Tc2 are Associated With Active Cytomegalovirus Infection in Infant Liver Transplant Recipients.
    Transplant Proc. 2024 Dec 4:S0041-1345(24)00581.
    

    >> Share

    
    September 2024
11. WEN YC, Wang YL, Chang TY, Hsiao YW, et al
    Comparison of Cytomegalovirus Reactivation in Children After Allogeneic Hematopoietic Cell Transplantation in 2 Transplant Eras.
    Transplant Proc. 2024 Sep 3:S0041-1345(24)00469.
    

    >> Share

    
    August 2024
12. SCHERGER SJ, Molina KC, Palestine AG, Pecen PE, et al
    Cytomegalovirus Retinitis in the Modern Era of Solid Organ Transplantation.
    Transplant Proc. 2024 Aug 14:S0041-1345(24)00431.
    

    >> Share

    
    June 2024
13. GARCIA-CAMPA M, Cisneros MR, Hinojosa MD, Cauich-Carrilo J, et al
    Gastrointestinal Cytomegalovirus Infection in a Transplantation Recipient With a Negative Serum Viral Load: Case Report.
    Transplant Proc. 2024 Jun 21:S0041-1345(24)00270.
    

    >> Share

    
    March 2024
14. SAVAS EM, Yegin ZA, Kok MI, Karayel HT, et al
    Hypomagnesemia May Predict Better Survival and Reduced Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Transplant Proc. 2024;56:386-393.
    

    >> Share

    
    February 2024
15. LEE JH, Lee H, Kim K, Lee SW, et al
    High-Dose Intravenous Immunoglobulin to Treat Anti-Thymocyte Globulin Induction-Related BK Virus and Cytomegalovirus Infection in Patients with ABO-Incompatible Kidney Transplantation.
    Transplant Proc. 2024 Feb 21:S0041-1345(24)00028.
    

    >> Share

    
    
16. KWON OK, Jeong ES, Lee KW, Choi MR, et al
    Monitoring Porcine Cytomegalovirus in Both Donors and Recipients is Crucial for Recipient's Survival in Pig-to-Cynomolgus Xenotransplantation.
    Transplant Proc. 2024 Feb 19:S0041-1345(24)00022.
    

    >> Share

    
    
17. GRAF M, Tuly R, Pednekar P, Wang C, et al
    Gaining Consensus Around Patient Risk Groups and Prognostic Profiles to Guide CMV Management Among Patients With Allogeneic Hematopoietic Stem Cell Transplant: Insights From a Delphi Panel With Hematopoietic Stem Cell Transplant Experts.
    Transplant Proc. 2024 Feb 17:S0041-1345(24)00077.
    

    >> Share

    
    
18. KLEIBOEKER H, Descourouez JL, Schulz LT, Mandelbrot DA, et al
    Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients.
    Transplant Proc. 2024 Feb 13:S0041-1345(24)00061.
    

    >> Share

    
    
19. IDE K, Tanaka A, Tanaka Y, Nakano R, et al
    Anti-Donor T-Cell Responses Are Not Necessarily Attenuated During Cytomegalovirus Infection in Kidney Transplant Recipients.
    Transplant Proc. 2024 Feb 7:S0041-1345(24)00050.
    

    >> Share

    
    January 2024
20. FARKAS K, Varga M, Dinnyes I, Rem L, et al
    Low-Dose vs Standard-Dose Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplantation: A Single-Center Retrospective Analysis.
    Transplant Proc. 2024 Jan 9:S0041-1345(23)00783.
    

    >> Share

    
    
21. LO TY, Wang YL, Jaing TH, Chang TY, et al
    Early Allogeneic Transplantation Favorably Influences the Outcome of Pediatric Acute Myeloid Leukemia-A Retrospective Study in a Single Center Over 2 Decades.
    Transplant Proc. 2024;56:201-210.
    

    >> Share

    
    September 2023
22. ROMAO EA, Yamamoto AY, Gaspar GG, Garcia TMP, et al
    Significant Increase in Cytomegalovirus (CMV) Infection in Solid Organ Transplants Associated With Increased Use of Thymoglobulin as Induction Therapy?
    Transplant Proc. 2023 Sep 29:S0041-1345(23)00564.
    

    >> Share

    
    
23. SAHIN AZ, Ozdemir O, Usalan O, Erdur FM, et al
    Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk.
    Transplant Proc. 2023;55:1551-1554.
    

    >> Share

    
    July 2023
24. SHIINA Y, Kawabe M, Suehiro Y, Katsumata H, et al
    Peripheral Blood Absolute Lymphocyte Count as a Predictor of Cytomegalovirus Infection in Kidney Transplant Recipients.
    Transplant Proc. 2023 Jul 7:S0041-1345(23)00398.
    

    >> Share

    
    April 2023
25. TOYA K, Tomimaru Y, Kobayashi S, Ito T, et al
    Impact of Cytomegalovirus Infection and Disease on Graft Loss After Pancreas Transplantation: A Single-Institution Study in Japan.
    Transplant Proc. 2023 Apr 29:S0041-1345(23)00223.
    

    >> Share

    
    
26. ISHIKAWA S, Tasaki M, Saito K, Nakagawa Y, et al
    Acquisition of Antibody Against Cytomegalovirus After Kidney Transplantation in Seronegative Recipients.
    Transplant Proc. 2023 Apr 13:S0041-1345(23)00126.
    

    >> Share

    
    
27. TANAKA A, Ide K, Tanaka Y, Sasaki Y, et al
    Evaluation of T-Cell Immune Status of Reduced-Dose Cyclosporine and Everolimus Combination Therapy in Kidney Transplant Patients.
    Transplant Proc. 2023 Apr 8:S0041-1345(23)00138.
    

    >> Share

    
    January 2023
28. HELLEMANS R, Bertels A, Wijtvliet V, Wouters K, et al
    Is Polyomavirus-Associated Nephropathy More Common in Kidney Transplant Recipients Exposed to Valganciclovir? A Retrospective Single Center Analysis.
    Transplant Proc. 2023 Jan 4:S0041-1345(22)00781.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share